Huntsman Stock To Go Ex-dividend Tomorrow (HUN)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

NEW YORK ( TheStreet) -- The ex-dividend date for Huntsman Corporation (NYSE: HUN) is tomorrow, September 12, 2012. Owners of shares as of market close today will be eligible for a dividend of 10 cents per share. At a price of $14.93 as of 9:30 a.m. ET, the dividend yield is 2.7%.

The average volume for Huntsman has been four million shares per day over the past 30 days. Huntsman has a market cap of $3.47 billion and is part of the basic materials sector and chemicals industry. Shares are up 46.3% year to date as of the close of trading on Monday.

Huntsman Corporation engages in the manufacture and sale of differentiated organic and inorganic chemical products worldwide. The company has a P/E ratio of 10.4, above the average chemicals industry P/E ratio of 9.6 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Huntsman as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, growth in earnings per share, increase in net income, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full Huntsman Ratings Report.

See our dividend calendar or top-yielding stocks list.

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
null

If you liked this article you might like

Wynn Stock Tanks Following Sexual Misconduct Allegations Against CEO

Wynn Stock Tanks Following Sexual Misconduct Allegations Against CEO

CVS Health, Intuitive Surgical, Allergan: 'Mad Money' Lightning Round

CVS Health, Intuitive Surgical, Allergan: 'Mad Money' Lightning Round

Long Live the FAANNG Stocks: Cramer's 'Mad Money' Recap (Tuesday 12/19/17)

Long Live the FAANNG Stocks: Cramer's 'Mad Money' Recap (Tuesday 12/19/17)

Clariant Shares Edge Higher After CEO Says Open To Working With Activist

Clariant Shares Edge Higher After CEO Says Open To Working With Activist

Airbus, BP and Clariant - Earnings Round-Up

Airbus, BP and Clariant - Earnings Round-Up